|  
             GUIDELINES 
              FOR REQUESTING RECOMBINANT ADENOVIRUS 
              
              
            Prior 
              to the submission of a request for recombinant adenovirus, each 
              requestor must read and adhere to the following guidelines; 
            
              -  
                
	All requests 
                  should be given to either Allan Prejusa or Trupti Mehta, phone:(713) 
                  792-8905. 
               
              -  
                
	A separate 
                  form should be filled out for each virus requested.  
               
              -  
                
	Please 
                  indicate the minimum amount of virus required based on either 
                  total number of viral particles (O.D.) and/or number of infection 
                  particles (plaque forming units). Approximately 30% more will 
                  be given to allow for loss during pipetting, etc.  
               
              -  
                
	All 
                  virus will be supplied in frozen form unless otherwise requested. 
                  All virus should be stored frozen at -80°C and diluted in 
                  appropriate buffers, e.g. PBS, just prior to use. Avoid to freeze 
                  diluted virus, or repeatedly freeze/thaw the virus as a significant 
                  loss of viral titer will occur.  
               
              -  
                
 If a large 
                  amount of vector is requested (> 1 ml of concentrated vector 
                  (1~2 x 1012 particle/ml)), please notify the Vector 
                  Core one month prior to the date of vector being provided.  
               
              -  
                
 Production 
                  of new vectors requires 6 weeks prior to the date of the vector 
                  being provided. All new vectors must be approved by Institutional 
                  Biosafety Committee before they can be produced in the Vector 
                  Core.  
               
             
 
            
           |